TARGETING THE EXTRA DOMAIN A FROM FIBRONECTIN FOR CANCER THERAPY WITH CAR-T CELLS

被引：0
|
作者：
Martin-Otal, C. [1 ]
Lasarte-Cia, A. [1 ]
Serrano, D. [2 ]
Casares, N. [1 ]
Navarro, F. [1 ]
Sarrion, P. [1 ]
Gorraiz, M. [1 ]
De-Andrea, C. [3 ]
Echeveste, J. [3 ]
Rodriguez-Madoz, J. R. [4 ]
Miguel, J. San [5 ]
Prosper, F. [4 ]
Hervas-Stubbs, S. [1 ]
Lasarte, J. J. [1 ]
Lozano, T. [1 ]
机构：
[1] Univ Navarra, CIMA, Program Immunol & Immunotherapy, Pamplona, Spain
[2] CIMA, Solid Tumors, Pamplona, Spain
[3] Clin Univ Navarra, Dept Pathol, Pamplona, Spain
[4] CIMA, Hematooncol, Pamplona, Spain
[5] Clin Univ Navarra, Hematol, Pamplona, Spain
来源：
HUMAN GENE THERAPY | 2022年 / 33卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
EP005
引用
收藏
页码：A9 / A10
页数：2
相关论文
共 50 条
  • [1] Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
    Martin-Otal, Celia
    Lasarte-Cia, Aritz
    Serrano, Diego
    Casares, Noelia
    Conde, Enrique
    Navarro, Flor
    Sanchez-Moreno, Ines
    Gorraiz, Marta
    Sarrion, Patricia
    Calvo, Alfonso
    De Andrea, Carlos E.
    Echeveste, Jose
    Vilas, Amaia
    Rodriguez-Madoz, Juan Roberto
    San Miguel, Jesus
    Prosper, Felipe
    Hervas-Stubbs, Sandra
    Lasarte, Juan Jose
    Lozano, Teresa
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (08)
  • [2] Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells (vol 10, e004479corr1, 2022)
    Martin-Otal, C.
    Lasarte-Cia, A.
    Serrano, D.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (09)
  • [3] CAR-T Therapy Targets Extra Domain B of Fibronectin Positive Solid Tumor Cells
    Tang, Jie
    Liu, Nan
    Zhu, Yongjie
    Li, Yi
    Zhao, Xudong
    IMMUNOLOGICAL INVESTIGATIONS, 2023, 52 (08) : 985 - 996
  • [4] CAR-T therapy: Prospects in targeting cancer stem cells
    Cui, Xiaoyue
    Liu, Rui
    Duan, Lian
    Cao, Dan
    Zhang, Qiaoling
    Zhang, Aijie
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (21) : 9891 - 9904
  • [5] ROR1-targeting switchable CAR-T cells for cancer therapy
    Haiyong Peng
    Thomas Nerreter
    Katrin Mestermann
    Jakob Wachter
    Jing Chang
    Michael Hudecek
    Christoph Rader
    Oncogene, 2022, 41 : 4104 - 4114
  • [6] ROR1-targeting switchable CAR-T cells for cancer therapy
    Peng, Haiyong
    Nerreter, Thomas
    Mestermann, Katrin
    Wachter, Jakob
    Chang, Jing
    Hudecek, Michael
    Rader, Christoph
    ONCOGENE, 2022,
  • [7] ROR1-targeting switchable CAR-T cells for cancer therapy
    Peng, Haiyong
    Nerreter, Thomas
    Mestermann, Katrin
    Wachter, Jakob
    Chang, Jing
    Hudecek, Michael
    Rader, Christoph
    ONCOGENE, 2022, 41 (34) : 4104 - 4114
  • [8] Correction: ROR1-targeting switchable CAR-T cells for cancer therapy
    Haiyong Peng
    Thomas Nerreter
    Katrin Mestermann
    Jakob Wachter
    Jing Chang
    Michael Hudecek
    Christoph Rader
    Oncogene, 2024, 43 : 992 - 992
  • [9] CAR-T Cell Therapy: From the Shop to Cancer Therapy
    Uscanga-Palomeque, Ashanti Concepcion
    Chavez-Escamilla, Ana Karina
    Alvizo-Baez, Cynthia Aracely
    Saavedra-Alonso, Santiago
    Terrazas-Armendariz, Luis Daniel
    Tamez-Guerra, Reyes S.
    Rodriguez-Padilla, Cristina
    Alcocer-Gonzalez, Juan Manuel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (21)
  • [10] CAR-T-Cell Therapy for Solid Tumors Positive for Fibronectin Extra Domain B
    Zhang, Zhijie
    Liu, Chang
    Yang, Zhe
    Yin, Hongping
    CELLS, 2022, 11 (18)
12345